QC PINK BISMUTH STOMACH RELIEF- bismuth subsalicylate tablet, chewable 
CHAIN DRUG MARKETING ASSOCIATION

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

QC Pink Bismuth Subsalicylate 262mg 30 Chewable Tablets

Active ingredient (in each tablet)

Bismuth subsalicylate 262 mg

Purpose

Upset stomach reliever and antidiarrheal

Uses

relieves:

travelers’ diarrhea
diarrhea
upset stomach due to overindulgence in food and drink, including:
heartburn
indigestion
nausea
gas
belching
fullness

Warnings

Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert: Contains salicylate. Do not take if you are

allergic to salicylates (including aspirin)
taking other salicylate products

Do not use if you have

an ulcer
a bleeding problem
bloody or black stool

Ask a doctor before use if you have

fever
mucus in the stool

Ask a doctor or pharmacist before use if you are taking any drug for

anticoagulation (thinning of the blood)
diabetes
gout
arthritis

When using this product

a temporary, but harmless, darkening of the stool and/or tongue may occur.

Stop use and ask a doctor if
symptoms get worse or last more than 2 days
ringing in the ears or loss of hearing occurs
diarrhea lasts more than 2 days

If pregnant or breast-feeding, ask a health professional before use.

Keep Out of Reach of Children

In case of overdose, get medical help or contact a Poison Control Center immediately at 1-800-222-1222

Directions

chew completely or dissolve tablets in mouth.
adults and children 12 years and older: 2 tablets (1 dose) every ½ hour to 1 hour as needed
do not exceed 8 doses (16 tablets) in 24 hours
use until diarrhea stops but not more than 2 days
children under 12 years: ask a doctor
drink plenty clear fluids to help prevent dehydration caused by diarrhea.

Other information

each tablet contains: salicylate 102 mg
store at room temperature.
avoid excessive heat
keep this carton for future reference on full labeling

TAMPER EVIDENT: Do not use if printed inner wrap is broken or missing.

Inactive ingredients

flavor, magnesium stearate, microcrystalline cellulose, red# 27 aluminum lake, sorbitol, sucralose.

Questions?

248-449-9300

Principal Display

QUALITY CHOICE®

NDC# 63868-421-30

Compare to the active ingredient in PEPTO-BISMOL®

Pink Bismuth

Stomach Relief

Bismuth Subsalicylate 262 mg

Soothing Relief for: Upset stomach, Indigestion, Nausea, Heartburn, Diarrhea

Original Flavor

30 Chewable Tablets

QC SATISFACTION GUARANTEED

DISTRIBUTED BY:

C.D.M.A., Inc.

43157 W. Nine Mile

Novi, MI 48376-0995

www.qualitychoice.com

Questions: 248-449-9300

*This product is not manufactured or distributed by PROCTER & GAMBLE INC., the distributor of Pepto-Bismol®

Quality Choice Pink Bismuth 30 Chewable Tablets
QC PINK BISMUTH  STOMACH RELIEF
bismuth subsalicylate tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63868-421
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (SALICYLIC ACID - UNII:O414PZ4LPZ) BISMUTH SUBSALICYLATE262 mg
Inactive Ingredients
Ingredient NameStrength
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
SORBITOL (UNII: 506T60A25R)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
Product Characteristics
ColorPINKScoreno score
ShapeROUNDSize17mm
FlavorImprint Code RP124
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63868-421-305 in 1 CARTON02/24/2020
16 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33502/24/2020
Labeler - CHAIN DRUG MARKETING ASSOCIATION (011920774)

Revised: 3/2020
Document Id: a6ce7a58-bdbf-472d-af2f-014b07f12266
Set id: a6ce7a58-bdbf-472d-af2f-014b07f12266
Version: 1
Effective Time: 20200319
 
CHAIN DRUG MARKETING ASSOCIATION